Chest, Vol 84, 669-678, Copyright © 1983 by American College of Chest Physicians

ARTICLES

The clinical profile of unresolved pulmonary embolism

JR Benotti, IS Ockene, JS Alpert and JE Dalen

Nearly all patients with pulmonary embolism (PE) have complete clinical and hemodynamic and at least near complete roentgenographic and angiographic resolution within four to six weeks of the acute event. To classify the syndrome of unresolved pulmonary embolism we reviewed our experience and that of the English literature to extract 30 well- described cases. The mean age at presentation was 45 years, and most patients were less than 60 years old. Almost all complained of dyspnea, and the majority had at least one clinical event suggestive of PE. Most had clinical evidence of pulmonary hypertension. Roentgenographic, arterial blood gas and electrocardiographic findings were nonspecific, though the perfusion lung scan was always abnormal. Most patients exhibited mild-to-moderate pulmonary hypertension. The severity of pulmonary artery obstruction was quite variable and did not correlate with the magnitude of arterial hypoxemia or pulmonary hypertension. Most patients did not improve with long-term anticoagulation therapy and underwent pulmonary embolectomy with acceptable mortality. Postoperative improvement correlated with improved arterial blood gas levels, abatement of pulmonary hypertension, and more satisfactory pulmonary perfusion.

This article has been cited by other articles:

				N. Galie and N. H. S. Kim Pulmonary Microvascular Disease in Chronic Thromboembolic Pulmonary Hypertension Proceedings of the ATS, September 1, 2006; 3(7): 571 - 576. [Abstract] [Full Text] [PDF]

				M. M. Madani and S. W. Jamieson Pulmonary Thromboendarterectomy Card. Surg. Adult, January 1, 2003; 2(2003): 1205 - 1228. [Full Text]

				J. E. Dalen Pulmonary Embolism: What Have We Learned Since Virchow?: Treatment and Prevention Chest, November 1, 2002; 122(5): 1801 - 1817. [Full Text] [PDF]

				D. Tscholl, F. Langer, O. Wendler, H. Wilkens, T. Georg, and H.-J. Schafers Pulmonary thromboendarterectomy - risk factors for early survival and hemodynamic improvement Eur. J. Cardiothorac. Surg., June 1, 2001; 19(6): 771 - 776. [Abstract] [Full Text] [PDF]

				N. M. Goldstein, M. H. Kollef, S. Ward, and B. F. Gage The Impact of the Introduction of a Rapid D-Dimer Assay on the Diagnostic Evaluation of Suspected Pulmonary Embolism Arch Intern Med, February 26, 2001; 161(4): 567 - 571. [Abstract] [Full Text] [PDF]

				E. J.R. van Beek Thromboembolic Disease : Can Echocardiography Assist Management? Chest, October 1, 2000; 118(4): 888 - 889. [Full Text] [PDF]

				D. A. Roberts, W. B. Gefter, J. A. Hirsch, R. R. Rizi, L. Dougherty, R. E. Lenkinski, J. S. Leigh Jr, and M. D. Schnall Pulmonary Perfusion: Respiratory-triggered Three-dimensional MR Imaging with Arterial Spin Tagging-Preliminary Results in Healthy Volunteers Radiology, September 1, 1999; 212(3): 890 - 895. [Abstract] [Full Text]

				I. Kutinsky, S. Blakley, and V. Roche Normal D-Dimer Levels in Patients With Pulmonary Embolism Arch Intern Med, July 26, 1999; 159(14): 1569 - 1572. [Abstract] [Full Text] [PDF]

				I. M. Lang, K. M. Moser, and R. R. Schleef Expression of Kunitz Protease Inhibitor–Containing Forms of Amyloid ß-Protein Precursor Within Vascular Thrombi Circulation, December 1, 1996; 94(11): 2728 - 2734. [Abstract] [Full Text]

				V. H. D. Bruyn, S. R. Bergmann, B. A. Keyt, and B. E. Sobel Visualization of Thrombi in Pulmonary Arteries With Radiolabeled, Enzymatically Inactivated Tissue-Type Plasminogen Activator Circulation, September 1, 1995; 92(5): 1320 - 1325. [Abstract] [Full Text]

				J. Gorcsan III, T. D. Edwards, G. M. Ziady, W. E. Katz, and B. P. Griffith Transesophageal Echocardiography to Evaluate Patients With Severe Pulmonary Hypertension for Lung Transplantation Ann. Thorac. Surg., March 1, 1995; 59(3): 717 - 722. [Abstract] [Full Text]